AR241676A1 - Suministrador de agente beneficioso a un ambiente de uso. - Google Patents

Suministrador de agente beneficioso a un ambiente de uso.

Info

Publication number
AR241676A1
AR241676A1 AR88311835A AR31183588A AR241676A1 AR 241676 A1 AR241676 A1 AR 241676A1 AR 88311835 A AR88311835 A AR 88311835A AR 31183588 A AR31183588 A AR 31183588A AR 241676 A1 AR241676 A1 AR 241676A1
Authority
AR
Argentina
Prior art keywords
sheet
agent delivery
period
passage
compartment
Prior art date
Application number
AR88311835A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of AR241676A1 publication Critical patent/AR241676A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

UN SUMINISTRADOR DE AGENTE BENEFICIOSO A UN AMBIENTE DE USO, COMPRENDE: (A) UNA PARED FORMADA POR UNA COMPOSICION SEMIPERMEABLE QUE ES PERMEABLE AL PASAJE DE FLUIDO E IMPERMEABLE AL PASAJE DE AGENTE BENEFICIOSO, LA PARED RODEANDO Y FORMANDO; (B) UN COMPARTIMIENTO; (C)UNA PRIMERA LAMINA EN EL COMPARTIMIENTO QUE COMPRENDE UN GEL CELULOSICO Y ES LIBERADA EN UN PERIODO CORTO DE TIEMPO, ESTANDO LA PRIMERA LAMINA EN CONTACTO CON (D)UNA SEGUNDA LAMINA EN EL COMPARTIMIENTO QUE COMPRENDE UN GEL CELULOCICO DIFERENTE Y ES LIBERADA EN UN PERIODO PROLONGADA DE TIEMPO Y (E)UN PASAJE DE LA SALIDA QUE COMUNICA EL EXTERIOR DEL SUMINISTRADOR CON LA PRIMERA LAMINAESTANDO EL PASAJE DE SALIDA CONFIGURADO Y DIMENSIONADO PARA SUMINISTRAR A TRAVES DEL MISMO LA PRIMERA LAMINA AL AMBIENTE DE USOEN UN PERIODO CORTO DE TIEMPO Y LUEGO SUMINISTRAR AL AMBIENTE DE USO A TRAVES DEL MISMO PASAJE LA SEGUNDA LAMINA EN UN PERIODO PROLONGADO DE TIEMPO.
AR88311835A 1987-09-03 1988-09-02 Suministrador de agente beneficioso a un ambiente de uso. AR241676A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/092,857 US4814181A (en) 1987-09-03 1987-09-03 Dosage form comprising fast agent delivery followed by slow agent delivery

Publications (1)

Publication Number Publication Date
AR241676A1 true AR241676A1 (es) 1992-10-30

Family

ID=22235509

Family Applications (1)

Application Number Title Priority Date Filing Date
AR88311835A AR241676A1 (es) 1987-09-03 1988-09-02 Suministrador de agente beneficioso a un ambiente de uso.

Country Status (23)

Country Link
US (1) US4814181A (es)
JP (1) JPH0196116A (es)
KR (1) KR950006216B1 (es)
AR (1) AR241676A1 (es)
AT (1) AT400296B (es)
AU (1) AU612397B2 (es)
BE (1) BE1001184A3 (es)
CA (1) CA1288016C (es)
CH (1) CH676794A5 (es)
DE (1) DE3829942A1 (es)
DK (1) DK485588A (es)
ES (1) ES2008580A6 (es)
FI (1) FI884056A (es)
FR (1) FR2620025B1 (es)
GB (1) GB2209280B (es)
IE (1) IE61845B1 (es)
IT (1) IT1223798B (es)
LU (1) LU87326A1 (es)
NL (1) NL8802180A (es)
NO (1) NO176902C (es)
PT (1) PT88404B (es)
SE (1) SE8803084L (es)
ZA (1) ZA886435B (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
RO112810B1 (ro) * 1991-12-27 1998-01-30 Merck & Co Inc Dispozitiv de eliberare controlata a unui medicament sub forma unei dispersii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
ES2194210T3 (es) * 1996-08-16 2003-11-16 Alza Corp Forma de dosificacion para suministrar una dosis ascendente de farmaco.
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
TR200300731T2 (tr) 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
DK1575566T3 (da) * 2002-12-26 2012-03-26 Pozen Inc Flerlagsdoseringsformer indeholdende naproxen og triptaner
NZ586198A (en) * 2003-09-26 2011-12-22 Alza Corp Oros push-stick sustained release dosage forms for controlled delivery of active agents
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
PL1889198T3 (pl) 2005-04-28 2015-04-30 Proteus Digital Health Inc System farmakologiczno-informatyczny
US20070190137A1 (en) * 2005-10-07 2007-08-16 Reyes Iran Osmotic dosage form with controlled release and fast release aspects
EP1954249B1 (en) * 2005-11-18 2015-07-22 Glaxo Group Limited Machine and method for pharmaceutical and pharmaceutical-like product assembly
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2120945A1 (en) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamine combination
US8404275B2 (en) 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
BR122013009559A2 (pt) 2009-04-28 2019-08-06 Proteus Digital Health, Inc. Marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
KR20130045261A (ko) 2010-04-07 2013-05-03 프로테우스 디지털 헬스, 인코포레이티드 소형의 섭취가능한 장치
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CN104105478A (zh) 2011-10-28 2014-10-15 维塔利斯公司 抗发红组合物
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR102051875B1 (ko) 2016-07-22 2019-12-04 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 이벤트 마커의 전자기 감지 및 검출
KR102426632B1 (ko) 2016-10-26 2022-07-29 오오쯔까세이야꾸가부시끼가이샤 섭취 가능한 이벤트 마커를 갖는 캡슐을 제조하는 방법
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
KR20180071226A (ko) 2018-06-12 2018-06-27 김성규 관성을 이용한 자동차 연료 절약 장치
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4475916A (en) * 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
GB2189702B (en) * 1986-04-30 1989-10-18 Alza Corp Dosage form with improved delivery capability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine

Also Published As

Publication number Publication date
SE8803084D0 (sv) 1988-09-02
FI884056A (fi) 1989-03-04
DK485588A (da) 1989-03-04
IE882641L (en) 1989-03-03
DK485588D0 (da) 1988-09-01
NO883837D0 (no) 1988-08-29
AT400296B (de) 1995-11-27
DE3829942A1 (de) 1989-03-16
PT88404A (pt) 1989-07-31
ZA886435B (en) 1989-05-30
BE1001184A3 (fr) 1989-08-08
US4814181A (en) 1989-03-21
GB2209280B (en) 1991-09-04
SE8803084L (sv) 1989-03-04
CA1288016C (en) 1991-08-27
NO883837L (no) 1989-03-06
NO176902C (no) 1995-06-21
LU87326A1 (fr) 1989-03-08
GB8820460D0 (en) 1988-09-28
PT88404B (pt) 1993-02-26
IT8867790A0 (it) 1988-09-02
FR2620025B1 (fr) 1990-04-20
NL8802180A (nl) 1989-04-03
FI884056A0 (fi) 1988-09-02
IT1223798B (it) 1990-09-29
FR2620025A1 (fr) 1989-03-10
GB2209280A (en) 1989-05-10
AU612397B2 (en) 1991-07-11
IE61845B1 (en) 1994-11-30
CH676794A5 (es) 1991-03-15
ES2008580A6 (es) 1989-07-16
ATA214488A (de) 1995-04-15
NO176902B (no) 1995-03-13
KR950006216B1 (ko) 1995-06-12
AU2152688A (en) 1989-03-09
KR890004684A (ko) 1989-05-09
JPH0196116A (ja) 1989-04-14

Similar Documents

Publication Publication Date Title
AR241676A1 (es) Suministrador de agente beneficioso a un ambiente de uso.
SE8601791D0 (sv) Osmotisk anordning med sjelvforseglande passage
DK144686A (da) Indretning til reguleret afgivning
ATE12891T1 (de) Medikamentenabgabemittel, das eine mikroporoese diffusionsmembrane aufweist.
DK196189A (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
MX174160B (es) Dispositivo osmotico con un miembro impulsor de hidrogel
ES282407U (es) Una capsula osmotica para la liberacion a velocidad controlada de una formulacion de un agente util
FI924419A0 (fi) Ett osmotiskt doseringssystem foer frigoerande av laekemedel i vaetskeform.
MX9203556A (es) Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina.
ES481877A1 (es) Un metodo para la liberacion controlada en agua de un com- puesto activo, en especial de un compuesto clorante y bacte-ricida.
ES2055677T1 (es) Procedimiento de obtencion de una composicion para el tratamiento de la disfuncion erectil.
AR006484A1 (es) Composición farmacéutica con efecto anestésico, uso de esta composición para la fabricación de medicamentos, y proceso para la fabricación de esta composición .
DE3265043D1 (en) Applicators for pharmaceutically active agents, their preparation and use
IT8449184A1 (it) Agente attivo nel trattamento di tossicomania in particolare da eroina costituito da una composizione contenente ibogaina
SE7613035L (sv) Osmotiskt driven avgivningsanordning med en av kompositmaterial bestaende vegg
IT1003512B (it) Apparecchio per l uso nella deter minazione in vitro di una sostanza attiva in un fluido corporale
SE7903973L (sv) Doseringssystem
FR2168422A1 (en) Vaginal deodorant - in aerosol form contg a non irritating organic powder
ES2040891T3 (es) Nuevo sistema plastificante hidrofilo y goma de mascar que contiene el mismo.
FR2158580A7 (en) Cotton wool impregnated with active substa - nces for medical and hygienic use
FR1592M (fr) Agents d'activation de cellules kératinogenes de l'organisme.
BE800728A (fr) Dispositif de controle d'etancheite de corps creux notamment de reservoirs de gaz sous pression ou d'enceintes analogues
MX154788A (es) Mejoras en procedimiento para preparar una estructura dispensadora osmoticamente actuada para dispensar una composicion de agente activo a un ambiente que contiene un fluido biologico en el cual la composicion de agente activo es soluble
JPS51115281A (en) Positive electrode for use in medical electrolyzed-water producing uni t